創薬における人工知能の市場規模、シェア&トレンド分析レポート:アプリケーション別(薬物最適化&再利用、前臨床試験)、治療分野別、地域別、セグメント別予測、2022年~2030年Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030 創薬における人工知能の市場成長とトレンド Grand View Research, Inc.の新しいレポートによると、創薬における人工知能の世界市場規模は2030年までに91億米ドルに達すると予測されています。2022年から2030年... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー創薬における人工知能の市場成長とトレンドGrand View Research, Inc.の新しいレポートによると、創薬における人工知能の世界市場規模は2030年までに91億米ドルに達すると予測されています。2022年から2030年にかけては、CAGR29.4%で拡大すると予測されています。パンデミックにより、製薬業界ではAIの導入が広まっています。AIとその関連プラットフォームは、医療画像や診断、慢性疾患の管理、薬剤設計の強化を目指している。同じデータをスキャンするAIシステムと比較すると、全体的に人間が費やす時間ははるかに多くなり、全体的なコストを削減し、より実現可能なアプローチとなります。 薬剤最適化および再利用アプリケーションセグメントは、2021年に最大の収益シェアを占めた。AIプラットフォームは、薬物の標的タンパク質の特定に役立ち、薬物が持ちうる有害事象や副作用を判断することができます。薬物分子は、より効果的で副作用を最小限にするために再利用することができます。企業のポートフォリオ薬剤は、新薬開発を早めるために、より速いペースでAIプラットフォームを使用して変更し、研究することができます。 2021年には、腫瘍治療分野セグメントが最大の収益シェアを占めた。製薬会社の大半は、AIスタートアップ企業と提携し、がん研究を最適化しているが、これはまだ未知の領域であり、発見されることは多い。AIシステムは、徹底的に訓練された放射線科医でさえ、通常のスキャンが示すよりもずっと早い段階でがんを特定することができます。その結果、寿命を延ばすことができ、また、がん研究や医薬品開発のために研究すべきマーカーを特定することができます。患者は、自分の遺伝子構成に適した治療法を処方されることができます。 2021年の市場は、北米が支配的だった。現在、多くのテック企業が、製薬会社でのAI活用に向けて資金と労力を投入している。IBMやマイクロソフトなどのテック大手企業は、複数の適応症に対するより迅速な医薬品開発や臨床試験のために、研究機関と協力関係を結んでいる。発展途上国も、薬剤開発や疾病把握のためにAI技術を導入することで、費用対効果の高い方策を見出そうとしています。 創薬における人工知能市場レポートハイライト - 薬物の最適化と再利用のアプリケーションセグメントが市場を支配し、2021年の収益シェアは50.0%超を占めた - 治療分野別では、腫瘍分野が20.0%超の収益シェアを占め、2021年に最大となった予測期間中は、感染症セグメントが最も速い成長率を記録すると予想される - アジア太平洋地域は、2022年から2030年にかけて最も速いCAGR32.2%で拡大すると予想されています。これは、この地域の発展途上国の間で、病気を理解し創薬を支援する手段としてAIの導入が進んでいることに起因している - 北米は市場をリードし、2021年の収益シェアは55.0%超を占めた。米国は人工知能技術の先駆者であり、この地域の市場成長に大きく寄与しています。 目次Table of ContentsChapter 1 Methodology and Scope 1.1 Research Methodology 1.1.1 Information Procurement 1.2 Information or Data Analysis 1.3 Market Formulation & Validation 1.4 Segment Share Calculation 1.5 List of Secondary Sources Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope 3.1 Market Segmentation 3.2 Artificial Intelligence in Drug Discovery Market Dynamics 3.2.1 Market Driver Analysis 3.2.2 Market Restraint Analysis 3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis 3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter’s Analysis Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis 4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis 4.2 Drug Optimisation and Repurposing 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 - 2030 (USD Million) 4.3 Preclinical Testing 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 - 2030 (USD Million) 4.4 Other Applications 4.4.1 Other Applications Market Estimates And Forecasts, 2016 - 2030 (USD Million) Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis 5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis 5.2 Oncology 5.2.1 Oncology Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.3 Neurodegenerative Diseases 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.4 Cardiovascular Disease 5.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.5 Metabolic Diseases 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.6 Infectious Disease 5.6.1 Infectious Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.7 Others 5.7.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million) Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis 6.1 Global Artificial Intelligence in Drug Discovery Market Movement Ananlysis, By region 6.2 Global Artificial Intelligence in Drug Discovery Market Share, By region, 2021 & 2030 6.3 North America 6.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.3.2 U.S. 6.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.3.3 Canada 6.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4 Europe 6.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.2 U.K. 6.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.3 Germany 6.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.4 France 6.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.5 Spain 6.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.6 Italy 6.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.7 Russia 6.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5 Asia Pacific 6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.2 China 6.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.3 India 6.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.4 Japan 6.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.5 Australia 6.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.6 Singapore 6.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.7 South Korea 6.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6 Latin America 6.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6.2 Brazil 6.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6.3 Mexico 6.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6.4 Argentina 6.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7 MEA 6.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7.2 South Africa 6.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7.3 Saudi Arabia 6.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7.4 UAE 6.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) Chapter 7 Competitive Analysis 7.1 Recent Developments & Impact Analysis, By Key Market Participants 7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players) 7.3. Competitive Dashboard & Company Market Position Analysis 7.3.1 Synergy Analysis: Major Deals & Strategic Alliances 7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators Chapter 8 Competitive Landscape 8.1 IBM Watson 8.1.1 Company Overview 8.1.2 Finanacial Performance 8.1.3 Offerings 8.1.4 Strategic Initiatives 8.2 Exscientia 8.2.1 Company Overview 8.2.2 Finanacial Performance 8.2.3 Offerings 8.2.4 Strategic Initiatives 8.3 GNS Healthcare 8.3.1 Company Overview 8.3.2 Finanacial Performance 8.3.3 Offerings 8.3.4 Strategic Initiatives 8.4 Alphabet (DeepMind) 8.4.1 Company Overview 8.4.2 Finanacial Performance 8.4.3 Offerings 8.4.4 Strategic Initiatives 8.5 Benevolent AI 8.5.1 Company Overview 8.5.2 Finanacial Performance 8.5.3 Offerings 8.5.4 Strategic Initiatives 8.6 BioSymetrics 8.6.1 Company Overview 8.6.2 Finanacial Performance 8.6.3 Offerings 8.6.4 Strategic Initiatives 8.7 Euretos. 8.7.1 Company Overview 8.7.2 Finanacial Performance 8.7.3 Offerings 8.7.4 Strategic Initiatives 8.8 Berg Health 8.8.1 Company Overview 8.8.2 Finanacial Performance 8.8.3 Offerings 8.8.4 Strategic Initiatives 8.9 Atomwise 8.9.1 Company Overview 8.9.2 Finanacial Performance 8.9.3 Offerings 8.9.4 Strategic Initiatives 8.10 Insitro 8.10.1 Company Overview 8.10.2 Finanacial Performance 8.10.3 Offerings 8.10.4 Strategic Initiatives 8.11 Cyclica 8.11.1 Company Overview 8.11.2 Finanacial Performance 8.11.3 Offerings 8.11.4 Strategic Initiatives
SummaryArtificial Intelligence In Drug Discovery Market Growth & Trends Table of ContentsTable of ContentsChapter 1 Methodology and Scope 1.1 Research Methodology 1.1.1 Information Procurement 1.2 Information or Data Analysis 1.3 Market Formulation & Validation 1.4 Segment Share Calculation 1.5 List of Secondary Sources Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope 3.1 Market Segmentation 3.2 Artificial Intelligence in Drug Discovery Market Dynamics 3.2.1 Market Driver Analysis 3.2.2 Market Restraint Analysis 3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis 3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter’s Analysis Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis 4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis 4.2 Drug Optimisation and Repurposing 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 - 2030 (USD Million) 4.3 Preclinical Testing 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 - 2030 (USD Million) 4.4 Other Applications 4.4.1 Other Applications Market Estimates And Forecasts, 2016 - 2030 (USD Million) Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis 5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis 5.2 Oncology 5.2.1 Oncology Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.3 Neurodegenerative Diseases 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.4 Cardiovascular Disease 5.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.5 Metabolic Diseases 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.6 Infectious Disease 5.6.1 Infectious Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million) 5.7 Others 5.7.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million) Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis 6.1 Global Artificial Intelligence in Drug Discovery Market Movement Ananlysis, By region 6.2 Global Artificial Intelligence in Drug Discovery Market Share, By region, 2021 & 2030 6.3 North America 6.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.3.2 U.S. 6.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.3.3 Canada 6.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4 Europe 6.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.2 U.K. 6.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.3 Germany 6.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.4 France 6.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.5 Spain 6.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.6 Italy 6.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.4.7 Russia 6.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5 Asia Pacific 6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.2 China 6.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.3 India 6.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.4 Japan 6.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.5 Australia 6.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.6 Singapore 6.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.5.7 South Korea 6.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6 Latin America 6.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6.2 Brazil 6.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6.3 Mexico 6.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.6.4 Argentina 6.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7 MEA 6.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7.2 South Africa 6.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7.3 Saudi Arabia 6.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) 6.7.4 UAE 6.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million) Chapter 7 Competitive Analysis 7.1 Recent Developments & Impact Analysis, By Key Market Participants 7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players) 7.3. Competitive Dashboard & Company Market Position Analysis 7.3.1 Synergy Analysis: Major Deals & Strategic Alliances 7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators Chapter 8 Competitive Landscape 8.1 IBM Watson 8.1.1 Company Overview 8.1.2 Finanacial Performance 8.1.3 Offerings 8.1.4 Strategic Initiatives 8.2 Exscientia 8.2.1 Company Overview 8.2.2 Finanacial Performance 8.2.3 Offerings 8.2.4 Strategic Initiatives 8.3 GNS Healthcare 8.3.1 Company Overview 8.3.2 Finanacial Performance 8.3.3 Offerings 8.3.4 Strategic Initiatives 8.4 Alphabet (DeepMind) 8.4.1 Company Overview 8.4.2 Finanacial Performance 8.4.3 Offerings 8.4.4 Strategic Initiatives 8.5 Benevolent AI 8.5.1 Company Overview 8.5.2 Finanacial Performance 8.5.3 Offerings 8.5.4 Strategic Initiatives 8.6 BioSymetrics 8.6.1 Company Overview 8.6.2 Finanacial Performance 8.6.3 Offerings 8.6.4 Strategic Initiatives 8.7 Euretos. 8.7.1 Company Overview 8.7.2 Finanacial Performance 8.7.3 Offerings 8.7.4 Strategic Initiatives 8.8 Berg Health 8.8.1 Company Overview 8.8.2 Finanacial Performance 8.8.3 Offerings 8.8.4 Strategic Initiatives 8.9 Atomwise 8.9.1 Company Overview 8.9.2 Finanacial Performance 8.9.3 Offerings 8.9.4 Strategic Initiatives 8.10 Insitro 8.10.1 Company Overview 8.10.2 Finanacial Performance 8.10.3 Offerings 8.10.4 Strategic Initiatives 8.11 Cyclica 8.11.1 Company Overview 8.11.2 Finanacial Performance 8.11.3 Offerings 8.11.4 Strategic Initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
Grand View Research 社の最新刊レポート
本レポートと同じKEY WORD(application drug)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/07 10:27 155.63 円 167.26 円 203.27 円 |